Evidence map›Paper›PMID 28966583›Full record

ArticleCase reports in oncology

Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report.

Hiroyuki Hirakawa, Takayoshi Kiba, Yuko Saito, Yoshiteru Watanabe, Takahiro Suzuki, Nobuo Ota

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hiroyuki HirakawaDepartment of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Takayoshi KibaDepartment of Clinical Oncology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Yuko SaitoDepartment of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Yoshiteru WatanabeDepartment of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Takahiro SuzukiDepartment of Otorhinolaryngology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Nobuo OtaDepartment of Otorhinolaryngology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Tohoku Medical and Pharmaceutical University Hospital · JPNational Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenoid cystic carcinoma (ACC) is a rare form of adenocarcinoma, which is a broad term describing any cancer that begins in the glandular tissues. It can be found in the head and neck. We report a patient with recurrent ACC arising from the submandibular gland, treated with 100 mg/m

Indexed as

Adenoid cystic carcinomaCase reportLactate dehydrogenaseNedaplatinSubmandibular gland

Identifiers

PMID28966583
PMCPMC5618449
OpenAlexW2750414501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.